X4 Pharmaceuticals (XFOR) Institutional Ownership

X4 Pharmaceuticals logo
$3.05 +0.22 (+7.77%)
As of 02:22 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for X4 Pharmaceuticals (NASDAQ:XFOR)

Current
Institutional Ownership
Percentage
72.03%
Number of
Institutional Buyers
(last 12 months)
41
Total
Institutional Inflows
(last 12 months)
$143.15M
Number of
Institutional Sellers
(last 12 months)
7
Total
Institutional Outflows
(last 12 months)
$4.64M
Get XFOR Insider Trade Alerts

Want to know when executives and insiders are buying or selling X4 Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

XFOR Institutional Buying and Selling by Quarter

X4 Pharmaceuticals Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/17/2026Goldman Sachs Group Inc.2,335,042$6.77M0.0%+154.8%2.355%
11/16/2026Integral Health Asset Management LLC250,000$725K0.0%N/A0.252%
11/13/2026 Palumbo Wealth Management LLC48,373$140K0.0%-27.9%0.049%
11/12/2026 State Street Corp1,730,123$5.02M0.0%-33.3%1.745%
11/6/2026 Russell Investments Group Ltd.213,258$618K0.0%+2,871.0%0.215%
11/3/2026 Alps Advisors Inc.130,424$378K0.0%+36.2%0.132%
9/9/2026 WINTON GROUP Ltd14,400$67K0.0%+35.8%0.015%
9/9/2026 Squarepoint Ops LLC67,078$313K0.0%N/A0.068%
8/21/2026 AXQ Capital LP22,880$107K0.0%N/A0.023%
8/21/2026Braidwell LP2,922,754$13.65M0.5%-10.7%2.948%
8/19/2026Wellington Management Group LLP51,800$242K0.0%N/A0.052%
8/6/2026 Bank of New York Mellon Corp196,340$917K0.0%N/A0.208%
7/9/2026 Pettinga Financial Advisors LLC10,000$47K0.0%N/A0.011%
5/29/2026Perceptive Advisors LLC6,737,648$27.83M0.5%+6.7%7.143%
5/19/2026Bank of America Corp DE150,676$622K0.0%+321.3%0.160%
5/19/2026Stempoint Capital LP850,742$3.51M0.7%-5.3%0.902%
5/16/2026SummitTX Capital L.P.11,200$46K0.0%N/A0.012%
5/15/2026 OMERS ADMINISTRATION Corp57,300$237K0.0%-47.5%0.061%
2/23/2026Virtu Financial LLC22,489$90K0.0%N/A0.026%
2/18/2026Susquehanna Portfolio Strategies LLC43,259$173K0.0%N/A0.049%
2/18/2026Perceptive Advisors LLC6,314,452$25.26M0.5%N/A7.222%
2/18/2026Millennium Management LLC55,978$224K0.0%-13.6%0.064%
2/18/2026Man Group plc24,187$97K0.0%N/A0.028%
2/18/2026Balyasny Asset Management L.P.64,505$258K0.0%N/A0.074%
2/17/2026Braidwell LP3,368,904$13.48M0.4%N/A3.853%
2/17/2026Bain Capital Life Sciences Investors LLC7,967,454$31.87M2.4%+227.0%9.112%
2/17/2026ExodusPoint Capital Management LP79,072$316K0.0%N/A0.090%
2/16/2026 Squarepoint Ops LLC12,518$50K0.0%N/A0.014%
2/16/2026 OMERS ADMINISTRATION Corp109,200$437K0.0%N/A0.125%
2/16/2026 Barclays PLC57,500$230K0.0%N/A0.066%
2/13/2026 Nantahala Capital Management LLC2,449,468$9.80M0.3%+9.9%2.801%
2/13/2026 Marshall Wace LLP80,456$322K0.0%N/A0.092%
2/13/2026 Affinity Asset Advisors LLC145,000$580K0.0%N/A0.166%
2/13/2026 Stifel Financial Corp20,496$82K0.0%N/A0.023%
2/13/2026 Kalehua Capital Management LLC3,722,840$14.89M13.8%N/A4.258%
2/13/2026 Hudson Bay Capital Management LP32,239$129K0.0%N/A0.037%
2/13/2026Charles Schwab Investment Management Inc.66,788$267K0.0%N/A0.076%
2/13/2026 Siren L.L.C.1,500,000$6M0.2%N/A1.715%
2/13/2026 State Street Corp198,234$793K0.0%+411.8%0.227%
2/12/2026 Jane Street Group LLC91,413$366K0.0%N/A0.105%
Pentagon magnet restrictions take effect January 1, 2027 (Ad)

A NASDAQ-listed company has signed a term sheet outlining a potential 75-year agreement with the U.S. Army. It would build and operate a rare earth processing facility on an active military base, with the Army receiving first right to production. The timing matters. New Pentagon restrictions on certain Chinese-origin rare earth magnets take effect January 1, 2027, while China controls more than 90% of global rare earth processing. The company's mine-to-magnet platform spans feedstock agreements, processing facilities, metallization technology, and downstream manufacturing, with initial commercial output targeted for 2027.tc pixel

Read the full breakdown of the proposed Army rare earth agreement and the company behind it.
2/12/2026Rosalind Advisors Inc.2,605,920$10.42M3.8%+68.7%2.980%
2/11/2026Empery Asset Management LP8,951,105$35.80M31.7%N/A10.237%
2/10/2026Goldman Sachs Group Inc.831,890$3.33M0.0%N/A0.951%
2/9/2026 Geode Capital Management LLC940,447$3.76M0.0%+1,080.6%1.076%
2/9/2026Jefferies Financial Group Inc.26,118$104K0.0%N/A0.030%
2/3/2026 Indivisible Partners10,000$40K0.0%N/A0.011%
1/21/2026 Palumbo Wealth Management LLC113,357$453K0.1%+18.9%0.130%
11/17/2025Acorn Capital Advisors LLC273,349$935K0.5%+77.8%0.313%
11/17/2025 Nantahala Capital Management LLC2,228,350$7.62M0.3%N/A2.548%
11/17/2025Millennium Management LLC64,795$222K0.0%-17.0%0.074%
11/17/2025Kingdon Capital Management L.L.C.933,332$3.19M0.4%+300.0%1.067%
11/17/2025Bank of America Corp DE19,304$66K0.0%-76.0%0.022%
11/17/2025Boothbay Fund Management LLC343,963$1.18M0.0%N/A0.393%
11/14/2025Deep Track Capital LP1,122,484$3.84M0.1%N/A9.838%
11/14/2025Two Sigma Investments LP13,868$47K0.0%N/A0.122%
11/13/2025Rosalind Advisors Inc.1,544,607$5.28M1.9%N/A13.537%
11/10/2025 Palumbo Wealth Management LLC95,327$326K0.1%N/A0.835%
11/7/2025Vanguard Group Inc.410,485$1.40M0.0%+77.0%3.598%
8/15/2025Bain Capital Life Sciences Investors LLC563,859$1.07M0.1%-96.7%9.738%
8/15/2025Acorn Capital Advisors LLC153,730$292K0.2%-97.9%2.655%
8/14/2025 Jane Street Group LLC97,344$185K0.0%+112.5%1.681%
8/14/2025OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC80,000$152K0.0%-68.3%1.382%
8/14/2025 Pale Fire Capital SE60,051$114K0.0%-97.0%1.037%
8/8/2025 Geode Capital Management LLC49,146$93K0.0%-98.6%0.849%
6/27/2025Goldman Sachs Group Inc.273,865$65K0.0%-42.7%4.730%
5/29/2025Rhumbline Advisers188,415$44K0.0%+5.4%3.255%
5/16/2025Goldman Sachs Group Inc.273,865$65K0.0%-42.7%4.731%
5/15/2025Kingdon Capital Management L.L.C.7,000,000$1.66M0.2%+41.8%120.919%
5/14/2025Pale Fire Capital SE2,035,362$481K0.1%+45.2%35.159%
5/9/2025Charles Schwab Investment Management Inc.481,528$114K0.0%+9.9%8.318%
2/17/2025Point72 Asset Management L.P.650,000$477K0.0%+4.0%0.381%
2/17/2025OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC 1,264,358$928K0.1%-18.4%0.741%
2/17/2025Millennium Management LLC258,759$190K0.0%-28.8%0.152%
2/17/2025Deutsche Bank AG267,628$195K0.0%+559.6%0.157%
2/17/2025Cantor Fitzgerald L. P.40,251$30K0.0%N/A0.024%
2/17/2025Bank of America Corp DE133,502$98K0.0%+20.3%0.078%
2/17/2025Acorn Capital Advisors LLC7,310,650$5.36M2.9%N/A4.287%
2/14/2025Jane Street Group LLC583,483$428K0.0%+134.9%0.342%
2/14/2025Schonfeld Strategic Advisors LLC1,392,826$1.02M0.0%-27.5%0.817%
2/14/2025Northern Trust Corp1,357,539$996K0.0%+2.9%0.796%
2/14/2025Stifel Financial Corp75,607$55K0.0%-38.3%0.044%
2/13/2025Invesco Ltd.62,073$46K0.0%-49.9%0.036%
2/13/2025Wells Fargo & Company MN78,518$58K0.0%+51.7%0.046%
2/12/2025Geode Capital Management LLC3,497,212$2.57M0.0%+1.4%2.051%
2/12/2025JPMorgan Chase & Co.459,653$337K0.0%+501.0%0.270%
1/31/2025Atria Wealth Solutions Inc.60,000$44K0.0%N/A0.035%
1/17/2025SG Americas Securities LLC183,152$134K0.0%+233.0%0.107%
11/19/2024Barclays PLC277,682$185K0.0%+196.0%0.163%
11/16/2024Geode Capital Management LLC3,447,512$2.31M0.0%-1.9%2.046%
11/15/2024Barclays PLC277,682$185K0.0%+196.0%0.165%
Don't lose access to this (Ad)

Ian Cooper is giving away his guide, The Simple Path To Success With Options, before it moves behind a paywall. The free download walks through strategies for navigating the options market, but the window to claim it is closing soon.tc pixel

Download your free copy before access ends for good
11/15/2024K2 Principal Fund L.P.89,158$60K0.0%-81.8%0.053%
11/15/2024XTX Topco Ltd157,642$106K0.0%+41.7%0.094%
11/15/2024Jane Street Group LLC248,447$166K0.0%+103.4%0.147%
11/15/2024State Street Corp2,952,895$1.98M0.0%+6.8%1.752%
11/15/2024Stifel Financial Corp122,448$82K0.0%-25.5%0.073%
11/15/2024Point72 Asset Management L.P.625,052$418K0.0%+15.1%0.371%
11/14/2024Verition Fund Management LLC44,355$30K0.0%N/A0.026%
11/14/2024Sio Capital Management LLC1,303,508$872K0.3%-47.9%0.774%
11/5/2024GSA Capital Partners LLP507,694$340K0.0%N/A0.301%
10/3/2024SG Americas Securities LLC55,004$37K0.0%N/A0.033%


XFOR Institutional Ownership - Frequently Asked Questions

During the previous two years, 59 institutional investors and hedge funds held shares of X4 Pharmaceuticals. The most heavily invested institutionals were Empery Asset Management LP ($35.80M), Bain Capital Life Sciences Investors LLC ($31.87M), Perceptive Advisors LLC ($27.83M), Kalehua Capital Management LLC ($14.89M), Braidwell LP ($13.65M), Rosalind Advisors Inc. ($10.42M), and Nantahala Capital Management LLC ($9.80M).Learn more on X4 Pharmaceuticals' institutional investors.

72.03% of X4 Pharmaceuticals' stock is owned by institutional investors. Learn more on XFOR's institutional investor holdings.

Of the 54 institutional investors that purchased X4 Pharmaceuticals' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Empery Asset Management LP ($8.95M), Acorn Capital Advisors LLC ($7.43M), Perceptive Advisors LLC ($6.74M), Bain Capital Life Sciences Investors LLC ($5.53M), Kalehua Capital Management LLC ($3.72M), Braidwell LP ($3.37M), and Kingdon Capital Management L.L.C. ($2.76M).

Institutional investors have bought a total of 36,236,540 shares in the last 24 months. This purchase volume represents approximately $143.15M in transactions.

The following institutional investors have sold X4 Pharmaceuticals stock in the last 24 months: State Street Corp ($861.91K), Braidwell LP ($350.20K), OMERS ADMINISTRATION Corp ($51.90K), Stempoint Capital LP ($47.72K), Palumbo Wealth Management LLC ($18.74K), and Millennium Management LLC ($8.82K).

Institutional investors have sold a total of 1,339,294 shares in the last 24 months. This volume of shares sold represents approximately $4.64M in transactions.



Institutional ownership data for NASDAQ:XFOR is compiled from quarterly 13F filings submitted to the U.S. Securities and Exchange Commission (SEC), with the most recent received on 11/17/2026. New 13F filings are added each quarter as they're published.
From Our Partners